Protein biomarker detection services
Our service leverages Quanterix SR-X™ and SP-X™ platforms to provide sensitive and precise measurement of protein biomarkers.
OUR BIOMARKER DETECTION PLATFORMS
Our in-house Quanterix SR-X™ and SP-X™ platforms allow for the ultra-sensitive detection and quantification of protein biomarkers at exceptionally low concentrations.
These platforms enable the simultaneous measurement of multiple proteins within a single sample, offering unparalleled precision and sensitivity.
Quanterix SR-X™
This platform allows multiplexed protein measurement of up to 4 analytes at concentrations as low as 0.1 fg/mL.
Its application extends to neurological biomarkers (Tau, NF-Light, GFAP, UCH-L1, Ab42 & Ab40, etc.), making it a valuable tool for studying conditions affecting the nervous system.
It is a revolutionary approach to immunoassay that utilizes micro-sized beads coated with capture antibodies to isolate and detect target biomolecules in a sample. This technology enables ultra-sensitive detection of proteins, nucleic acids, and other biomolecules, with detection limits down to the femtogram range.
Fig. Quanterix SR-X™ operating mode
Quanterix SP-X™
This versatile platform caters to immuno-oncology and inflammatory biomarkers, including IFNγ, IL-1β, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-22, and TNFα.
It enables multiplexed protein measurement with up to 10 analytes.
Our experts leverage this platform to detect proteins with an impressive sensitivity at concentrations as low as 10 fg/mL.
This innovative technology employs an array of capture antibodies immobilized on a glass slide to capture and identify target biomolecules. Known as Simoa® Planar Array Technology, its scalability allows for the analysis of hundreds of samples in parallel, making it exceptionally efficient for high-throughput applications.
Fig. Quanterix SP-X™ operating mode
Customized assays can be developed upon request to measure specific protein biomarkers.
The SIMOA® technology has applications in various fields, including biomarker research, diagnostics, and drug development. It can be used to detect and measure biomarkers related to Alzheimer's Disease, cancer, infectious diseases, and cardiovascular diseases, among others.
Why Firalis Molecular Precision Is the Best Partner for Your Project
Sensitive detection
SIMOA® technology allows the detection and quantification of individual molecules with high precision and sensitivity (fg/mL). The reported LOD of 0.2-1 fg/mL, depending on the assay.
Low sample input
Sample input is typically in the range of 25-50 μL for most Quanterix assays, which preserves precious samples and enables low-volume sample analysis.
High throughput
The Quanterix platforms offer high throughput capabilities, enabling the analysis of hundreds of samples in a single run.
Qualified Team
Our team boasts extensive experience in proteomics analysis and is dedicated to providing you with the best service and support throughout your project.
Dynamic range
A wide dynamic range, enabling the detection of both low and high abundance biomolecules in a single sample.
OUR COMMITMENT
Timeliness
We are committed to timely delivery and efficient project execution, ensuring that your research progresses according to schedule
Tailored Solutions
We are dedicated to understanding your goals and providing customized services with proactive communication throughout the project.
Quality Assurance
We follow strict, accredited procedures to guarantee the accuracy and reliability of your data.
Innovation
Our specialists leverage advanced technologies and methodologies to deliver innovative solutions tailored to your project.
